These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 7671249

  • 21. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
    Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.
    Cancer Res; 1993 Nov 01; 53(21):5225-32. PubMed ID: 8106143
    [Abstract] [Full Text] [Related]

  • 22. Structural characterization of the human interleukin-13 receptor alpha1 gene promoter.
    Ise T, Izumi H, Nagatani G, Takano H, Wada M, Kuwano M, Kohno K.
    Biochem Biophys Res Commun; 1999 Nov 19; 265(2):387-94. PubMed ID: 10558877
    [Abstract] [Full Text] [Related]

  • 23. [Preliminary analysis of the 5'-flanking region of rat gamma-glutamylcysteine synthetase catalytic subunit gene].
    Cheng LL, Li B, Tu HB, Liu QC, Ran PX.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar 19; 28(3):164-8. PubMed ID: 15854410
    [Abstract] [Full Text] [Related]

  • 24. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S, Inoue H, Flowers LC, Sidell N.
    Clin Cancer Res; 2003 Oct 01; 9(12):4627-35. PubMed ID: 14555539
    [Abstract] [Full Text] [Related]

  • 25. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K, Godwin AK, Ozols RF, Hamilton TC, O'Dwyer PJ.
    Cancer Res; 1993 Aug 15; 53(16):3662-6. PubMed ID: 8101766
    [Abstract] [Full Text] [Related]

  • 26. Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells.
    He Z, Li B, Yu L, Liu Q, Zhong N, Ran P.
    Respiration; 2008 Aug 15; 75(2):202-9. PubMed ID: 18032881
    [Abstract] [Full Text] [Related]

  • 27. Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line.
    Tarumoto T, Nagai T, Ohmine K, Miyoshi T, Nakamura M, Kondo T, Mitsugi K, Nakano S, Muroi K, Komatsu N, Ozawa K.
    Exp Hematol; 2004 Apr 15; 32(4):375-81. PubMed ID: 15050748
    [Abstract] [Full Text] [Related]

  • 28. Increased transcription of the regulatory subunit of gamma-glutamylcysteine synthetase in rat lung epithelial L2 cells exposed to oxidative stress or glutathione depletion.
    Tian L, Shi MM, Forman HJ.
    Arch Biochem Biophys; 1997 Jun 01; 342(1):126-33. PubMed ID: 9185621
    [Abstract] [Full Text] [Related]

  • 29. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD, Monks A, Barone L, Rosser D, Akerman G, Montali JA, Wheatley JB, Schmidt DE.
    Mol Pharmacol; 1996 Jul 01; 50(1):149-59. PubMed ID: 8700107
    [Abstract] [Full Text] [Related]

  • 30. [gamma-Glutamylcysteine synthetase and chemosensitivity].
    Nishio K, Kurokawa H, Ishida T, Fukuoka K, Saijo N.
    Gan To Kagaku Ryoho; 1997 Feb 01; 24(4):418-23. PubMed ID: 9063478
    [Abstract] [Full Text] [Related]

  • 31. Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines.
    Bonovich M, Olive M, Reed E, O'Connell B, Vinson C.
    Cancer Gene Ther; 2002 Jan 01; 9(1):62-70. PubMed ID: 11916245
    [Abstract] [Full Text] [Related]

  • 32. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration.
    Huang ZZ, Chen C, Zeng Z, Yang H, Oh J, Chen L, Lu SC.
    FASEB J; 2001 Jan 01; 15(1):19-21. PubMed ID: 11099488
    [Abstract] [Full Text] [Related]

  • 33. Interferon-gamma modulates the lipopolysaccharide-induced expression of AP-1 and NF-kappa B at the mRNA and protein level in human monocytes.
    de Wit H, Hoogstraten D, Halie RM, Vellenga E.
    Exp Hematol; 1996 Feb 01; 24(2):228-35. PubMed ID: 8641346
    [Abstract] [Full Text] [Related]

  • 34. Expression of glutathione and gamma-glutamylcysteine synthetase mRNA is Jun dependent.
    Sekhar KR, Meredith MJ, Kerr LD, Soltaninassab SR, Spitz DR, Xu ZQ, Freeman ML.
    Biochem Biophys Res Commun; 1997 May 29; 234(3):588-93. PubMed ID: 9175757
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of gamma-glutamylcysteine synthetase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1.
    Manna SK, Kuo MT, Aggarwal BB.
    Oncogene; 1999 Jul 29; 18(30):4371-82. PubMed ID: 10439045
    [Abstract] [Full Text] [Related]

  • 36. Increased DT-diaphorase expression and cross-resistance to mitomycin C in a series of cisplatin-resistant human ovarian cancer cell lines.
    O'Dwyer PJ, Perez RP, Yao KS, Godwin AK, Hamilton TC.
    Biochem Pharmacol; 1996 Jul 12; 52(1):21-7. PubMed ID: 8678904
    [Abstract] [Full Text] [Related]

  • 37. Reversal of cisplatin resistance in human ovarian cancer cell lines by a c-jun antisense oligodeoxynucleotide (ISIS 10582): evidence for the role of transcription factor overexpression in determining resistant phenotype.
    Pan B, Yao KS, Monia BP, Dean NM, McKay RA, Hamilton TC, O'Dwyer PJ.
    Biochem Pharmacol; 2002 May 01; 63(9):1699-707. PubMed ID: 12007573
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance.
    Jia Y, Zhang W, Liu H, Peng L, Yang Z, Lou J.
    Cancer Chemother Pharmacol; 2012 Feb 01; 69(2):377-85. PubMed ID: 21833590
    [Abstract] [Full Text] [Related]

  • 39. Glutathione content but not gamma glutamyl cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines.
    Newkirk K, Heffern J, Sloman-Moll E, Sessions RB, Rasmussen AA, Andrews PA, Cullen KJ.
    Cancer Chemother Pharmacol; 1997 Feb 01; 40(1):75-80. PubMed ID: 9137534
    [Abstract] [Full Text] [Related]

  • 40. MZF1 possesses a repressively regulatory function in ERCC1 expression.
    Yan QW, Reed E, Zhong XS, Thornton K, Guo Y, Yu JJ.
    Biochem Pharmacol; 2006 Mar 14; 71(6):761-71. PubMed ID: 16426580
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.